Beyond rankings: Learning (more) from algorithm validation.

Artificial intelligence Biomedical image analysis challenges Deep learning Endoscopic vision Generalized linear mixed models Grand challenges Image characteristics driven algorithm development Instrument segmentation Minimally invasive surgery Surgical data science

Journal

Medical image analysis
ISSN: 1361-8423
Titre abrégé: Med Image Anal
Pays: Netherlands
ID NLM: 9713490

Informations de publication

Date de publication:
05 2023
Historique:
received: 17 06 2021
revised: 24 05 2022
accepted: 08 02 2023
medline: 21 4 2023
pubmed: 26 3 2023
entrez: 25 3 2023
Statut: ppublish

Résumé

Challenges have become the state-of-the-art approach to benchmark image analysis algorithms in a comparative manner. While the validation on identical data sets was a great step forward, results analysis is often restricted to pure ranking tables, leaving relevant questions unanswered. Specifically, little effort has been put into the systematic investigation on what characterizes images in which state-of-the-art algorithms fail. To address this gap in the literature, we (1) present a statistical framework for learning from challenges and (2) instantiate it for the specific task of instrument instance segmentation in laparoscopic videos. Our framework relies on the semantic meta data annotation of images, which serves as foundation for a General Linear Mixed Models (GLMM) analysis. Based on 51,542 meta data annotations performed on 2,728 images, we applied our approach to the results of the Robust Medical Instrument Segmentation Challenge (ROBUST-MIS) challenge 2019 and revealed underexposure, motion and occlusion of instruments as well as the presence of smoke or other objects in the background as major sources of algorithm failure. Our subsequent method development, tailored to the specific remaining issues, yielded a deep learning model with state-of-the-art overall performance and specific strengths in the processing of images in which previous methods tended to fail. Due to the objectivity and generic applicability of our approach, it could become a valuable tool for validation in the field of medical image analysis and beyond.

Identifiants

pubmed: 36965252
pii: S1361-8415(23)00026-9
doi: 10.1016/j.media.2023.102765
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102765

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Part of this work was funded by the Helmholtz Imaging Platform (HIP), a platform of the Helmholtz Incubator on Information and Data Science and by the Surgical Oncology Program of the National Center for Tumor Diseases (NCT) Heidelberg.

Auteurs

Tobias Roß (T)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany; Medical Faculty, Heidelberg University, Heidelberg, Germany; Helmholtz Imaging, German Cancer Research Center (DKFZ), Heidelberg, Germany. Electronic address: t.ross@dkfz-heidelberg.de.

Pierangela Bruno (P)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Mathematics and Computer Science, University of Calabria, Rende, Italy.

Annika Reinke (A)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany; Helmholtz Imaging, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Mathematics and Computer Science, Heidelberg University, Germany.

Manuel Wiesenfarth (M)

Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Lisa Koeppel (L)

Section Clinical Tropical Medicine, Heidelberg University, Heidelberg, Germany.

Peter M Full (PM)

Medical Faculty, Heidelberg University, Heidelberg, Germany; Division of Medical Image Computing (MIC), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Bünyamin Pekdemir (B)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Patrick Godau (P)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Mathematics and Computer Science, Heidelberg University, Germany.

Darya Trofimova (D)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany; HIP Applied Computer Vision Lab, MIC, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Fabian Isensee (F)

Helmholtz Imaging, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Medical Image Computing (MIC), German Cancer Research Center (DKFZ), Heidelberg, Germany; HIP Applied Computer Vision Lab, MIC, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Tim J Adler (TJ)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Thuy N Tran (TN)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany.

Sara Moccia (S)

The BioRobotics Institute and Department of Excellence in Robotics and AI, Scuola Superiore Sant'Anna, Italy.

Francesco Calimeri (F)

Department of Mathematics and Computer Science, University of Calabria, Rende, Italy.

Beat P Müller-Stich (BP)

Department for General, Visceral and Transplantation Surgery, Heidelberg University Hospital, Heidelberg, Germany.

Annette Kopp-Schneider (A)

Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Lena Maier-Hein (L)

Intelligent Medical Systems (IMSY), German Cancer Research Center (DKFZ), Heidelberg, Germany; Medical Faculty, Heidelberg University, Heidelberg, Germany; Helmholtz Imaging, German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Mathematics and Computer Science, Heidelberg University, Germany; Germany and National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH